Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Versant Ventures
Biotech
After 'complete standstill,' biotech market reaches new normal
The first half of 2025 was brutal for biotech, but investors are still keen on therapeutics in several areas, such as cardiorenal and neuropsych.
Gabrielle Masson
Aug 20, 2025 11:04am
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Apr 25, 2025 8:30am
Versant unveils new autoimmune biotech with $100M fundraise
Apr 24, 2025 8:00am
Versant launches another obesity biotech with $65M series A
Jan 28, 2025 8:35am
Right out of the gate, Light Horse nabs $62M and Novartis deal
Jan 9, 2025 4:26pm
Antag secures $84M series A for GLP-1 add-on
Dec 4, 2024 3:00am
